125 related articles for article (PubMed ID: 32920743)
1. Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes.
Deman F; Punie K; Laenen A; Neven P; Oldenburger E; Smeets A; Nevelsteen I; Van Ongeval C; Baten A; Faes T; Christiaens M; Janssen H; Weltens C; Desmedt C; Wildiers H; Floris G
Breast Cancer Res Treat; 2020 Dec; 184(3):985-998. PubMed ID: 32920743
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.
Yang X; Rao J; Yang W; Shui R
Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444
[TBL] [Abstract][Full Text] [Related]
3. Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer.
Perez EA; Ballman KV; Tenner KS; Thompson EA; Badve SS; Bailey H; Baehner FL
JAMA Oncol; 2016 Jan; 2(1):56-64. PubMed ID: 26469139
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics, tumor-infiltrating lymphocytes, and prognosis in HER2-low breast cancer: A comparison study with HER2-zero and HER2-positive disease.
Lu Y; Tong Y; Fei X; Chen X; Shen K
Cancer Med; 2023 Aug; 12(15):16264-16278. PubMed ID: 37366301
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer.
Sønderstrup IMH; Jensen MB; Ejlertsen B; Eriksen JO; Gerdes AM; Kruse TA; Larsen MJ; Thomassen M; Laenkholm AV
Acta Oncol; 2019 Mar; 58(3):363-370. PubMed ID: 30614364
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.
de Boo LW; Jóźwiak K; Ter Hoeve ND; van Diest PJ; Opdam M; Wang Y; Schmidt MK; de Jong V; Kleiterp S; Cornelissen S; Baars D; Koornstra RHT; Kerver ED; van Dalen T; Bins AD; Beeker A; van den Heiligenberg SM; de Jong PC; Bakker SD; Rietbroek RC; Konings IR; Blankenburgh R; Bijlsma RM; Imholz ALT; Stathonikos N; Vreuls W; Sanders J; Rosenberg EH; Koop EA; Varga Z; van Deurzen CHM; Mooyaart AL; Córdoba A; Groen E; Bart J; Willems SM; Zolota V; Wesseling J; Sapino A; Chmielik E; Ryska A; Broeks A; Voogd AC; van der Wall E; Siesling S; Salgado R; Dackus GMHE; Hauptmann M; Kok M; Linn SC
ESMO Open; 2024 Mar; 9(3):102923. PubMed ID: 38452438
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer with invasive micropapillary components (IMPCs) shows high lymph node metastasis and a poor prognosis: A retrospective clinical study.
Guo Z; Yang Z; Li D; Tang J; Xu J; Shen H; Yuan Y
Medicine (Baltimore); 2020 May; 99(21):e20238. PubMed ID: 32481300
[TBL] [Abstract][Full Text] [Related]
8. Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis.
Onder S; Fayda M; Karanlık H; Bayram A; Şen F; Cabioglu N; Tuzlalı S; İlhan R; Yavuz E
Breast J; 2017 Nov; 23(6):638-646. PubMed ID: 28543794
[TBL] [Abstract][Full Text] [Related]
9. Stromal Tumor-Infiltrating Lymphocytes Associated with Immunohistopathology and Molecular Subtypes of Breast Cancer in Vietnam.
Duong TT; Pham DTN; Duong HNT; Ly TT; Thai TA
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2523-2530. PubMed ID: 37505787
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers.
Tian T; Ruan M; Yang W; Shui R
Oncotarget; 2016 Jul; 7(28):44395-44405. PubMed ID: 27323808
[TBL] [Abstract][Full Text] [Related]
11. Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer.
Kim RS; Song N; Gavin PG; Salgado R; Bandos H; Kos Z; Floris G; Eynden GGGMVD; Badve S; Demaria S; Rastogi P; Fehrenbacher L; Mamounas EP; Swain SM; Wickerham DL; Costantino JP; Paik S; Wolmark N; Geyer CE; Lucas PC; Pogue-Geile KL
J Natl Cancer Inst; 2019 Aug; 111(8):867-871. PubMed ID: 30888406
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy.
de Jong VMT; Wang Y; Ter Hoeve ND; Opdam M; Stathonikos N; Jóźwiak K; Hauptmann M; Cornelissen S; Vreuls W; Rosenberg EH; Koop EA; Varga Z; van Deurzen CHM; Mooyaart AL; Córdoba A; Groen EJ; Bart J; Willems SM; Zolota V; Wesseling J; Sapino A; Chmielik E; Ryska A; Broeks A; Voogd AC; Loi S; Michiels S; Sonke GS; van der Wall E; Siesling S; van Diest PJ; Schmidt MK; Kok M; Dackus GMHE; Salgado R; Linn SC
J Clin Oncol; 2022 Jul; 40(21):2361-2374. PubMed ID: 35353548
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.
Loi S; Drubay D; Adams S; Pruneri G; Francis PA; Lacroix-Triki M; Joensuu H; Dieci MV; Badve S; Demaria S; Gray R; Munzone E; Lemonnier J; Sotiriou C; Piccart MJ; Kellokumpu-Lehtinen PL; Vingiani A; Gray K; Andre F; Denkert C; Salgado R; Michiels S
J Clin Oncol; 2019 Mar; 37(7):559-569. PubMed ID: 30650045
[TBL] [Abstract][Full Text] [Related]
14. A Standardized Evaluation Method for FOXP3+ Tregs and CD8+ T-cells in Breast Carcinoma: Association With Breast Carcinoma Subtypes, Stage and Prognosis.
Papaioannou E; Sakellakis M; Melachrinou M; Tzoracoleftherakis E; Kalofonos H; Kourea E
Anticancer Res; 2019 Mar; 39(3):1217-1232. PubMed ID: 30842152
[TBL] [Abstract][Full Text] [Related]
15. Clinical/prognostic significance of Syndecan-1 expression in invasive breast carcinoma with distant metastasis and its correlation with tumor immunity.
Wang H; Zhang Y; Yang Z; Jiang Y; Wu L; Wang R; Zhang Z
Pathol Res Pract; 2023 Oct; 250():154787. PubMed ID: 37678063
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between lymph node metastasis and pathologic features of invasive micropapillary carcinoma of breast].
Guo XJ; Chen L; Lang RG; Fan Y; Fu L
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):8-12. PubMed ID: 16608641
[TBL] [Abstract][Full Text] [Related]
17. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.
Matsumoto H; Thike AA; Li H; Yeong J; Koo SL; Dent RA; Tan PH; Iqbal J
Breast Cancer Res Treat; 2016 Apr; 156(2):237-47. PubMed ID: 26960711
[TBL] [Abstract][Full Text] [Related]
18. Differences in the clinicopathological characteristics of pure and mixed invasive micropapillary breast carcinomas from eastern China.
Wang R; Li N; Wang XJ; Chen T; Zhang H; Cheng Y; Sun W; Chen Z; Zheng Y; Lizaso A; Chen S; Cao WM
Ann Transl Med; 2021 Mar; 9(5):412. PubMed ID: 33842633
[TBL] [Abstract][Full Text] [Related]
19. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).
Yu JI; Choi DH; Huh SJ; Cho EY; Kim K; Chie EK; Ha SW; Park IA; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Koo JS; Kim JH; Jeong BG; Kim IA; Lee JH; Park W
Clin Breast Cancer; 2015 Oct; 15(5):353-61.e1-2. PubMed ID: 25776197
[TBL] [Abstract][Full Text] [Related]
20. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma.
Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N
Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
